Stanniocalcin 2 Drives Malignant Transformation of Human Glioblastoma Cells by Targeting SNAI2 and Matrix Metalloproteinases

Scientists reported an association between human glycoprotein stanniocalcin-2 (STC2) and aggressive glioblastoma multiforme (GBM) progression, and demonstrated the underlying mechanism.